Abstract
Released to an American market in 2013 the pharmaceutical drug Osphena was heralded as an innovative, hormone-free therapeutic option to cure two dysfunctions associated with menopausal women’s bodies: vaginal atrophy and dyspareunia. Yet a critical examination of the drug, its advertising, and associated discourses presents an opportunity to explore not only the medicalization of aging but also direct-to-consumer advertising’s role in perpetuating ideologies concerned with normalcy, normal bodies, normal sex, and normal gender performance. This project undertakes a critical feminist analysis of Osphena’s advertising campaign and the public’s response, incorporating Foucaultian theory and a bioethical perspective, and ultimately re-contextualizing them within medical discourses that highlight the pharmaceutical benefits associated with widespread adoption of the “deficiency” perspective that the drug perpetuates. I claim that the Osphena campaign is a clear contemporary illustration that the age-old rhetoric of women’s bodies as requiring medical intervention to resist aging is far from passé, and suggest that images and rhetoric of empowerment would be more readily accepted without relying upon dated and clichéd depictions of female sexuality.
Similar content being viewed by others
References
Abraham, J. (2010). Pharmaceuticalization of society in context: Theoretical, empirical and health dimensions. Sociology, 44(4), 603–622.
Abraham, J. (2011). Evolving sociological analyses of ‘pharmaceuticalisation’: A response to Williams, Martin and Gabe. Sociology of Health & Illness, 33, 726–728.
Barker, K. K. (1998). A ship upon a stormy sea: The medicalization of pregnancy. Social Science and Medicine, 47(8), 1067–1076.
Bell, S. E. (1987). Changing ideas: The medicalization of menopause. Social Science and Medicine, 24(6), 535–542.
Bell, S. E. (1990). Sociological perspectives on the medicalization of menopause. Annals of the New York Academy of Sciences, 592(1), 173–178.
Bell, S. E., & Figert, A. E. (2012). Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward. Social Science and Medicine, 75, 775–783. doi:10.1016/j.socscimed.2012.04.002.
Bennett, T. (2003). Culture and governmentality. In J. Z. Bratich, J. Packer, & C. McCarthy (Eds.), Foucault, cultural studies, and governmentality (pp. 47–63). Albany, NY: State University of New York Press.
Birnbaum, G. E., Cohen, O., & Wertheimer, V. (2007). Is it all about intimacy? Age, menopausal status, and women’s sexuality. Personal Relationships, 14, 167–185.
Borell, K., & Karlsson, S. G. (2003). Reconceptualising intimacy and ageing: Living apart together. In S. Arber, K. Davidson, & J. Ginn (Eds.), Gender and ageing: Changing roles and relationships (pp. 47–62). Maidenhead: Open University Press.
Brown, M. T. (2009). LGBT aging and rhetorical silence. Sexuality Research and Social Policy, 6(2), 65–78.
Brown-Bowers, A., Gurevich, M., Vasilovsky, A. T., Cosma, S., & Matti, S. (2015). Managed not missing: Young women’s discourses of sexual desire within a postfeminist heterosexual marketplace. Psychology of Women Quarterly. doi:10.1177/0361684314567303.
Butler, J. (1999). Gender is burning: Questions of appropriation and subversion. In S. Thoram (Ed.), Feminist film theory: A reader (pp. 336–349). New York, NY: New York University Press.
Calasanti, T. M. (2007). Bodacious berry, potency wood and the aging monster: Gender and age relations in anti-aging ads. Social Forces, 86(1), 335–355. doi:10.1353/sof.2007.0091.
Calasanti, T., & King, N. (2007). “Beware of the estrogen assault”: Ideals of old manhood in anti-aging advertisements. Journal of Aging Studies, 21, 357–368.
Carpenter, L. M., Nathanson, C. A., & Kim, Y. J. (2006). Sex after 40? Gender, ageism, and sexual partnering in midlife. Journal of Aging Studies, 20, 93–106. doi:10.1016/j.jaging.2005.06.003.
Chrisler, J. C. (1996). PMS as a culture-bound syndrome. In J. C. Chrisler, C. Golden, & P. D. Rozee (Eds.), Lectures on the psychology of women (pp. 106–121). Bostom, MA: McGraw Hill.
Chrisler, J. C., & Caplan, P. (2002). The strange case of Dr. Jekyll and Ms. Hyde: How PMS became a cultural phenomenon and a psychiatric disorder. Annual Review of Sex Research, 13(1), 274–306. doi:10.1080/10532528.2002.10559807.
Clarke, L. H., & Griffin, M. (2007). The body natural and the body unnatural: Beauty work and aging. Journal of Aging Studies, 21, 187–201.
Colombo, C., Mosconi, P., Buratti, M. G., Liberati, A., Donati, S., Mele, A., & Satolli, R. (2010). Press coverage of hormone replacement therapy and menopause. European Journal of Obstetrics & Gynecology and Reproductive Biology, 153(1), 56–61.
Coney, S. (1993). The menopause industry: A guide to medicine’s ‘discovery’ of the mid-life woman. North Melbourne: Spinifex Press.
Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore, MD: The Johns Hopkins University Press.
Cox, A. D., & Cox, D. (2010). A defense of direct-to-consumer prescription drug advertising. Business Horizons, 53, 221–228.
de Beauvoir, S. (1973). The second sex. (H. M. Parshley, Trans.). New York, NY: Vintage Books.
DeLameter, J. D., & Sill, M. (2005). Sexual desire later in life. The Journal of Sexual Research, 42(2), 138–149.
Delbaere, M. (2013). Metaphors and myths in pharmaceutical advertising. Social Science and Medicine, 82, 21–29.
Derry, P. S. (2002). What do we mean by “the biology of menopause”? Sex Roles, 1(46), 13–23.
Dillaway, H. E. (2005). Menopause is the “good old”: Women’s thoughts about reproductive aging. Gender & Society, 19(3), 398–417.
Douglas, S. (2010). Enlightened sexism: The seductive message that feminism’s work is done. New York, NY: Times Books.
Dries, K. (2014, March 11). Meet Osphena, the new Viagra-esque drug treatment for women. Retrieved from http://jezebel.com/meet-osphena-that-new-viagra-esque-drug-for-women-1541607435/all.
Fishman, J. R., & Mamo, L. (2001). What’s in a disorder: A cultural analysis of medical and pharmaceutical constructions of male and female sexual dysfunction. Women & Therapy, 24(1/2), 179–193.
Foucault, M. (1986). The care of the self. New York, NY: Vintage Books.
Fox, N. J., & Ward, K. J. (2008). Pharma in the bedroom… and the kitchen… The pharmaceuticalisation of daily life. Sociology of Health & Illness, 30(6), 856–868.
Frank, R. T. (1941). Treatment of disorders of the menopause. Bulletin of the New York Academy of Medicine, 17, 854–863.
Frosch, D. L., May, S. G., Tietbohl, C., & Pagán, J. A. (2011). Living in the “land of no”? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs. Social Science and Medicine, 73, 995–1002.
Furman, F. K. (1997). Facing the mirror: Older women and beauty shop culture. New York, NY: Routledge.
Gannon, L., & Stevens, J. (1998). Portraits of menopause in the mass media. Women and Health, 27(3), 1–15.
Gellad, Z. F., & Lyles, K. W. (2007). Direct-to-consumer advertising of pharmaceuticals. The American Journal of Medicine, 120, 475–480.
Gill, R. (2007). Postfeminist media culture: Elements of a sensibility. European Journal of Cultural Studies, 10(2), 147–166.
Gledhill, S., & Schweitzer, R. D. (2013). Sexual desire, erectile dysfunction and the biomedicalization of sex in older heterosexual men. Journal of Advanced Nursing, 70(4), 894–903.
Gott, M. (2005). Sexuality, sexual health and ageing. Maidenhead: Open University Press.
Gott, M., & Hinchliff, S. (2003). How important is sex later in life? The views of older people. Social Science and Medicine, 56, 1617–1628.
Grady, D. (2013, October 1). Study of hormone use in menopause reaffirms complex mix of risks and benefits. Retrieved from http://www.nytimes.com/2013/10/02/health/new-study-reaffirmscomplexity-of-hormone-use-in-menopause.html.
Greene, J. G. (1984). The social and psychological origins of the climacteric syndrome. Aldershot: Power Publishing.
Grieveson, L. (2009). On governmentality and screens. Screen, 50(1), 1–8. doi:10.1093/screen/hjn079.
Hatch, L. (2011). The American Psychological Association task force on the sexualization of girls: A review, update and commentary. Sexual Addiction & Compulsivity, 18, 195–211. doi:10.1080/10720162.2011.613326.
Hayes, R. D. (2009). The prevalence of dyspareunia. In A. T. Goldstein, C. F. Pukall, & I. Goldstein (Eds.), Female sexual pain disorders: Evaluation and Management (pp. 3–8). Oxford: Wiley.
Hooks, B. (1984). Feminist theory from margin to center. Boston, MA: South End Press.
iSpot.tv, Inc. (2015). Osphena TV spot. Retrieved from http://www.ispot.tv/ad/7fjC/osphena.
Jones, E. K., Jurgenson, J. R., Katzenellenbogen, J. M., & Thompson, S. C. (2012). Menopause and the influence of culture: Another gap for indigenous Australian women? BMC Women’s Health, 12(43), 1–10.
Kase, N. (1974). Estrogens and the menopause. Journal of the American Medical Association, 227, 318–319.
Katz, A. (2007). When sex hurts: Menopause-related dyspareunia. American Journal of Nursing, 107(7), 34–39.
Katz, S., & Marshall, B. L. (2003). New sex for old: Lifestyle, consumerism, and the ethics of aging well. Journal of Aging Studies, 17, 3–16.
Kelly, J. (2008). A lesbian feminist analysis of the demise of hormone replacement therapy. Women’s Studies International Forum, 31, 300–307.
Kingsberg, S. A., Kellog, S., & Krychman, M. (2009). Treating dyspareunia caused by vaginal atrophy: A review of treatment options using vaginal estrogen therapy. International Journal of Women’s Health, 1, 105–111.
Koninchx, P. (1984). Menopause: The beginning of a curable disease or a lucky phenomenon. In H. Van Herendael, B. Van Herendael, F. E. Riphagen, L. Goessons, & H. van der Pas (Eds.), The climacteric: An update (pp. 3–10). Lancaster, PA: MTP Press.
Light, D. W., & Lexchin, J. R. (2012). Pharmaceutical research and development: What do we get for all that money? British Medical Journal. doi:10.1136/bmj.e4348.
Liu, Q., & Gupta, S. (2011). The impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: Empirical findings and public policy implications. International Journal of Research Marketing, 28, 205–217.
Lock, M. (1993). Encounters with aging: Mythologies of menopause in Japan and North America. Los Angeles, CA: University of California Press.
Loe, M. (2004). The rise of Viagra: How the little blue pill changed sex in America. New York: NY: New York University Press.
MacBride, M. B., Rhodes, D. J., & Shuster, L. T. (2010). Vulvovaginal atrophy. Mayo Clinic Proceedings, 85(1), 87–94. doi:10.4065/mcp.2009.0413.
Marshall, B. L., & Katz, S. (2006). From androgyny to androgens: Re-sexing the aging body. In T. M. Calasanti & K. F. Slevin (Eds.), Age matters: Realigning feminist thinking (pp. 75–97). New York, NY: Routledge.
Meyer, V. F. (2001). The medicalization of menopause: Critique and consequences. International Journal of Health Services, 31(4), 769–792.
Meyer, V. F. (2003). Medicalized menopause, U.S. style. Health Care for Women International, 24(9), 822–830.
Miller, T. (2008). Makeover nation: The United States of reinvention. Columbus, OH: The Ohio State University Press.
Montemurro, B., & Siefken, J. M. (2014). Cougars on the prowl? New perceptions of older women’s sexuality. Journal of Aging Studies, 28, 35–43.
Morrow, D. (2011, July 4). 8 weirdly sexual products you won’t believe are for kids. Retrieved from http://www.cracked.com/article_19288_8-weirdly-sexual-products-you-wont-believe-are-kids.html.
Mulvey, L. (1975). Visual pleasure and narrative cinema. Screens, 16(3), 6–18.
Nachtigall, L. E. (1990). The medicalization of menopause. Annals of the New York Academy of Sciences, 592, 179.
Obermeyer, C. M. (2000). Menopause across cultures: A review of the evidence. Menopause: The Journal of The North American Menopause Society, 7(3), 184–192.
Oudshoorn, N. (1990). On the making of sex hormones: Research materials and the production of knowledge. Social Studies of Science, 20, 5–33.
Ouellette, L., & Arcy, J. (2015). “Live through this”: Feminist care of the self 2.0. Frame, 28(1), 95–114.
Ouellette, L., & Hay, J. (2008). Better living through reality TV: Television and post-welfare citizenship. Malden, MA: Blackwell Publishing.
Padamsee, T. J. (2011). The pharmaceutical corporation and the ‘good work’ of managing women’s bodies. Social Science and Medicine, 72, 1342–1350. doi:10.1016/j.socscimed.2010.10.034.
Parens, E. (2013). On good and bad forms of medicalization. Bioethics, 27(1), 28–35.
Pickar, J. H., MacNeil, T., & Ohleth, K. (2010). SERMs: Progress and future perspectives. Maturitas, 67, 129–138.
Pines, W. L. (1999). A history and perspective on direct-to-consumer promotion. Food and Drug Law Journal, 54, 489–518.
Rose, N. (1992). Governing the enterprising self. In P. Heelas & P. Morris (Eds.), The values of the enterprise culture: The moral debate (pp. 141–164). New York, NY: Routledge.
Rose, N. (2001). The politics of life itself. Theory, Culture & Society, 18(6), 1–30.
Rowntree, M. R. (2014). ‘Comfortable in my own skin’: A new form of sexual freedom for ageing baby boomers. Journal of Aging Studies, 31, 150–158.
Shionogi & Co., Ltd. (2013a). Shionogi Annual Report. Retrieved from http://www.shionogi.co.jp/en/ir/pdf/pdf_13/all13.pdf.
Shionogi & Co., Ltd. (2013b). To Our Stakeholders. Retrieved from http://www.shionogi.co.jp/en/ir/pdf/pdf_13/stakeholders13.pdf.
Shionogi & Co., Ltd. (2014, March 31). About Shionogi. Retrieved from http://www.shionogi.co.jp/en/company/outline/index.html.
Shionogi Inc. (2014). VVA voices. Retrieved from http://www.vvavoices.com.
Shoebridge, A., & Steed, L. (1999). Discourse about menopause in selected print media. Australian and New Zealand Journal of Public Health, 23(5), 475–481.
Shorr, E. (1940). The menopause. Bulletin of the New York Academy of Medicine, 16, 453–474.
Simon, M. (2011, September 2). Toddler does Dolly: Where’s the line between dress-up, hyper-sexualization? Retrieved from http://go.galegroup.com/ps/i.do?id=GALE%7CA274750543&v=2.1&u=umn_wilson&it=r&p=EAIM&sw=w&asid=532353d438d251a07d8684295fc360ea.
Slevec, J., & Tiggemann, M. (2010). Attitudes toward cosmetic surgery in middle-aged women: Body image, aging anxiety, and the media. Psychology of Women Quarterly, 34, 65–74.
Smirnova, M. H. (2012). A will to youth: The woman’s anti-aging elixir. Social Science and Medicine, 75, 1236–1243.
Smith-Rosenberg, C. (1973). Puberty to menopause: The cycle of femininity in nineteenth-century America. Feminist Studies, 1, 58–72.
Tasca, C., Rapetti, M., Carta, M. G., & Fadda, B. (2012). Women and hysteria in the history of mental health. Clinical Practice & Epidemiology in Mental Health, 8, 110–119.
Thorneycroft, I. H. (1989). The role of estrogen replacement therapy in the prevention of osteoporosis. American Journal of Obstetrics and Gynecology, 160, 1306–1310.
Tilt, E. J. (1882). The change of life in health and disease: A clinical treatise on the diseases of the ganglionic nervous system incidental to women at the decline of life. New York, NY: Bermingham.
Ussher, J. M. (2003). The role of premenstrual dysphoric disorder in the subjectification of women. Journal of Medical Humanities, 24(1/2), 131–146.
Utz, R. L. (2011). Like mother, (not) like daughter: The social construction of menopause and aging. Journal of Aging Studies, 25, 143–154.
Van Keep, P. A., Greenblatt, R. B., & Albeaux-Fernet, M. (1976). Consensus on menopause research. Lancaster, PA: MTP Press.
Ward, L. M., Merriwether, A., & Caruthers, A. (2006). Breasts are for men: Media, masculinity ideologies, and men’s beliefs about women’s bodies. Sex Roles, 55, 703–714.
Wentzell, E. (2006). Bad bedfellows: Disability sex rights and Viagra. Bulletin of Science, Technology & Society, 26(5), 370–377.
Wilson, R. A. (1966). Feminine forever. New York, NY: Evans.
Winterich, J. A. (2003). Sex, menopause, and culture: Sexual orientation and the meaning of menopause for women’s sex lives. Gender and Society, 17(4), 627–642.
Woloshin, S., Schwartz, L. M., Tremmel, J., & Welch, H. G. (2001). Direct-to-consumer advertisements for prescription drugs: What are Americans being sold? The Lancet, 358, 1141–1146.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bedor, E. It’s Not You, It’s Your (Old) Vagina: Osphena’s Articulation of Sexual Dysfunction. Sexuality & Culture 20, 38–55 (2016). https://doi.org/10.1007/s12119-015-9308-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12119-015-9308-z